Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 39% ± 24% | |
epithelial cell | 6 studies | 25% ± 7% | |
endothelial cell | 5 studies | 30% ± 14% | |
microglial cell | 5 studies | 23% ± 5% | |
neuron | 4 studies | 22% ± 5% | |
GABAergic neuron | 4 studies | 43% ± 14% | |
astrocyte | 4 studies | 34% ± 12% | |
goblet cell | 4 studies | 33% ± 21% | |
interneuron | 4 studies | 34% ± 18% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 7% | |
macrophage | 3 studies | 23% ± 3% | |
transit amplifying cell | 3 studies | 28% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 31% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2132.31 | 1445 / 1445 | 100% | 21.86 | 183 / 183 |
intestine | 100% | 3191.05 | 966 / 966 | 100% | 41.90 | 527 / 527 |
bladder | 100% | 2726.90 | 21 / 21 | 100% | 26.03 | 503 / 504 |
stomach | 100% | 1832.84 | 358 / 359 | 100% | 33.46 | 286 / 286 |
lung | 100% | 2207.50 | 577 / 578 | 100% | 19.63 | 1153 / 1155 |
skin | 100% | 4011.36 | 1809 / 1809 | 100% | 30.38 | 470 / 472 |
uterus | 100% | 1975.29 | 170 / 170 | 100% | 20.22 | 457 / 459 |
breast | 100% | 2353.99 | 459 / 459 | 99% | 20.19 | 1111 / 1118 |
thymus | 100% | 1710.48 | 652 / 653 | 99% | 13.72 | 600 / 605 |
prostate | 100% | 1536.00 | 245 / 245 | 99% | 17.36 | 497 / 502 |
pancreas | 99% | 1353.38 | 326 / 328 | 99% | 17.70 | 176 / 178 |
ovary | 100% | 1855.15 | 180 / 180 | 97% | 11.69 | 417 / 430 |
kidney | 100% | 1240.37 | 89 / 89 | 96% | 9.54 | 861 / 901 |
brain | 93% | 1263.66 | 2459 / 2642 | 100% | 11.81 | 702 / 705 |
adrenal gland | 100% | 2178.56 | 258 / 258 | 93% | 10.52 | 213 / 230 |
liver | 99% | 1261.71 | 224 / 226 | 87% | 7.24 | 352 / 406 |
adipose | 100% | 2179.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.54 | 29 / 29 |
muscle | 100% | 6142.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1816.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.89 | 1 / 1 |
blood vessel | 100% | 1840.14 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 15.47 | 78 / 80 |
heart | 96% | 1772.13 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 1400.77 | 829 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0070012 | Molecular function | oligopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | PREP |
Protein name | Prolyl endopeptidase (EC 3.4.21.-) Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prolyl endopeptidase |
Synonyms | PEP |
Description | FUNCTION: Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long. |
Accessions | ENST00000369110.8 A0A499FJL1 ENST00000652536.2 H0Y5Y0 P48147 ENST00000448705.1 |